Ikarian Capital, LLC

Q3 2026 13F-HR Holdings

Location
Dallas, TX
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
172
Total value ($000)
$994,154
Net value change ($000)
+65,980 (7.1%)
New positions
19
Sold out positions
20
Turnover %
19.8%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AMLX 14,228 674.3%
KOD 9,252 22.4%
ORIC 7,042 NEW
DAMORA THERAPEUTICS INC 5,867 NEW
FREENOME INC 5,711 NEW
PHVS 5,255 49.2%
HELP 5,118 585.6%
SNSE 5,054 571.1%
IMNM 4,859 382.3%
VOR 4,770 NEW
Top Reduces (Value $000, Stocks/ETFs)
ALMS -24,193 -98.8%
PRAX -22,365 -91.7%
ABVX -14,912 -34.4%
CAPR -12,378 -85.1%
ANIP -11,693 -51.9%
TENX -11,202 -97.7%
RLMD -9,407 -63.3%
BHVN -9,355 -84.0%
GLTO -8,732 -100.0%
CNTB -8,343 -77.2%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 490,041 (49.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type